Korrie Mack is a biochemist with a strong foundation in protein misfolding, aggregation and biochemistry, and she has broad research experience in protein engineering, reversing protein aggregation and neurodegeneration. As a scientist in the biology group at Neumora Therapeutics, she supports both internal and external efforts for the preclinical programs in neurodegeneration, including initiatives focusing on biochemistry, mechanism-of-action, disease modeling and work on translational biomarkers. Dr. Mack has a strong collaborative spirit, demonstrated by her interactions with teams working on translation, chemistry, preclinical and data science to support advancement of preclinical neurodegeneration programs. She completed her PhD in biochemistry and molecular biophysics at the University of Pennsylvania and undertook postdoctoral training in neuroscience at Merck.